Pro-Dex Inc is primarily active in the medical device industry.

The main competitors of Pro-Dex Inc in the market include companies such as Danaher Corporation, Intuitive Surgical Inc, and Medtronic plc.

Pro-Dex Inc., a leading technology company, has a rich history and background. Founded in 1978, it has emerged as a prominent player in the manufacturing industry. Pro-Dex specializes in designing and producing high-quality motion control systems and precision instruments. With a strong focus on innovation and customer satisfaction, the company has established a global presence in various sectors including medical, aerospace, and dental. Pro-Dex Inc. is committed to providing cutting-edge solutions through continuous research and development. Its dedication to excellence and customer-centric approach has propelled Pro-Dex Inc. to become a trusted name in the industry.

Pro-Dex Inc, a leading company in the stock market, has achieved several significant milestones. From its inception, Pro-Dex Inc has been dedicated to providing innovative solutions to various industries. Over the years, the company has successfully diversified its product portfolio, offering cutting-edge technologies and superior performance. Pro-Dex Inc has also demonstrated consistent growth, expanding its market presence and surpassing industry expectations. Additionally, the company has successfully established strong partnerships and collaborations, enabling it to enhance its product offerings and drive further success. Pro-Dex Inc's commitment to excellence and its ability to adapt and evolve have contributed to its remarkable achievements and positioned it as a top contender in the market.

Pro-Dex Inc is primarily present in the United States.

Pro-Dex Inc represents a set of core values and a corporate philosophy focused on innovation, quality, and customer satisfaction. With a commitment to excellence, Pro-Dex Inc strives to deliver cutting-edge technology and solutions in the areas of motion control, medical devices, and robotics. The company aims to meet and exceed customer expectations by continuously improving its products and services, while also fostering a culture of integrity, teamwork, and respect. Pro-Dex Inc's dedication to innovation and customer-centric approach sets it apart in the market, driving its growth and success in the industry.

Analysts currently set an average price target of 57,12 USD for the Pro-Dex stock (median: 57,12 USD), implying -14,8 % versus the latest price. The consensus is based on 7 analyst ratings.

Pro-Dex Cílové ceny analytiků 2026

7 analysts currently rate the Pro-Dex stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Pro-Dex to generate revenue of 76,40 Mil. USD and earnings per share of 4,01 USD.

Pro-Dex Cílové ceny analytiků 2026

Converted at the current exchange rate, the Pro-Dex share trades at 57,92 EUR (67,02 USD).

The Pro-Dex share (PDEX) is listed on 2 stock exchanges, including: NASDAQ (PDEX), Frankfurt (PDXN.F).

Pro-Dex Inc is a company specializing in the development and manufacturing of high-precision components and instruments for medical and dental applications. Their business model is based on three main segments: medical technology, dental technology, and industrial technology. They offer a wide range of products in the medical technology field, such as surgical instruments, catheters, endoscopes, and other medical devices. In the dental technology sector, they produce precision instruments for dentists worldwide. And in the industrial technology segment, they provide precision components for various industries, including aerospace, automotive, electronics, and more. Their business model focuses on high manufacturing competence, innovative solutions tailored to customer needs, and a strong emphasis on quality. They work closely with their customers to meet the high standards required in the medical, dental, and industrial fields.

Tržby očekávané za Pro-Dex činí 76,40 Mil. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.

Zisk očekávané za Pro-Dex činí 13,24 Mil. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.

Poměr ceny k zisku (P/E) Pro-Dex je aktuálně 16,73. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Pro-Dex.

Poměr ceny k tržbám (P/S) Pro-Dex je aktuálně 2,90. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Pro-Dex.

Score kvality pro Pro-Dex je 7/10.

ISIN Pro-Dex je US74265M2052. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.

WKN Pro-Dex je A1C0JP. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.

Ticker Pro-Dex je PDEX. Symbol tickeru se používá k obchodování akcií Pro-Dex na burze.

Pro-Dex vyplácela dividendu každý rok během posledních 0 let.

Pro-Dex je přiřazena sektoru 'Zdravotnictví'.

Dividendy Pro-Dex jsou vypláceny v USD.